Pumps in Practice: Practical Aspects of Continuous Subcutaneous Insulin Infusion (CSII)
1984; Wiley; Volume: 1; Issue: 1 Linguagem: Inglês
10.1111/j.1464-5491.1984.tb01917.x
ISSN1464-5491
Autores Tópico(s)Natural Antidiabetic Agents Studies
ResumoDiabetic MedicineVolume 1, Issue 1 p. 27-32 Pumps in Practice: Practical Aspects of Continuous Subcutaneous Insulin Infusion (CSII) Continuous Subcutaneous Insulin Infusion as a Treatment Option: A Perspective After Seven Years of Research Applications J. C. Pickup, J. C. Pickup Department of Chemical Pathology, Guy's Hospital Medical School, London, SE1 9RT, UKSearch for more papers by this author J. C. Pickup, J. C. Pickup Department of Chemical Pathology, Guy's Hospital Medical School, London, SE1 9RT, UKSearch for more papers by this author First published: May 1984 https://doi.org/10.1111/j.1464-5491.1984.tb01917.xCitations: 11AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 Pickup JC, Keen H. Continuous subcutaneous insulin infusion: a developing tool in diabetes research. Diabetologia 1980; 18: 1–4. 10.1007/BF01228294 CASPubMedWeb of Science®Google Scholar 2 Pickup JC, Keen H, Viberti GC et al. Continuous subcutaneous insulin infusion in the treatment of diabetes mellitus. Diabetes Care 1980; 3: 290–300. 10.2337/diacare.3.2.290 CASPubMedWeb of Science®Google Scholar 3 Felig P, Tamborlane W, Sherwin RS, Genel M. Insulin-infusion pump for diabetes. N Engl J Med 1979; 301: 1004–1005. 10.1056/NEJM197911013011815 CASPubMedWeb of Science®Google Scholar 4 Pickup JC, Keen H, Parsons JA, Alberti KGMM. Continuous subcutaneous insulin infusion: an approach to achieving normoglycaemia. Br Med J 1978; 1: 204–207. 10.1136/bmj.1.6107.204 CASPubMedWeb of Science®Google Scholar 5 Pickup JC, Keen H, Parsons JA, Alberti KGMM. Continuous subcutaneous insulin infusion: good blood glucose control for up to 4 days. Diabetologia 1979; 16: 385–389. 10.1007/BF01223159 CASPubMedWeb of Science®Google Scholar 6 Pickup JC, Keen H, Parsons JA, Alberti KGMM, Rowe AS. Continuous subcutaneous insulin infusion: improved blood glucose and intermediary metabolite control in diabetics. Lancet 1979; 1: 1255–1258. 10.1016/S0140-6736(79)92225-6 CASPubMedWeb of Science®Google Scholar 7 Pickup JC, White MC, Keen H, Kohner EM, Parsons JA, Alberti KGMM. Long-term continuous subcutaneous insulin infusion in diabetics at home. Lancet 1979; 2: 870–873. 10.1016/S0140-6736(79)92686-2 CASPubMedWeb of Science®Google Scholar 8 Tamborlane WV, Sherwin RS, Genel M, Felig P. Reduction to normal of plasma glucose in juvenile diabetes by subcutaneous administration of insulin with a portable infusion pump. N Engl J Med 1979; 300: 573–578. 10.1056/NEJM197903153001101 CASPubMedWeb of Science®Google Scholar 9 Tamborlane WV, Sherwin RS, Genel M, Felig P. Restoration of normal lipid and amino acid metabolism in diabetic patients with a portable insulin infusion pump. Lancet 1979; 1: 1258–1261. 10.1016/S0140-6736(79)92226-8 PubMedWeb of Science®Google Scholar 10 Tamborlane WV, Sherwin RS, Genel M, Felig P. Outpatient treatment of juvenile-onset diabetes with a preprogrammed portable subcutaneous insulin infusion system. Am J Med 1980; 68: 190–196. 10.1016/0002-9343(80)90353-8 CASPubMedWeb of Science®Google Scholar 11 Champion MC, Shepherd GAA, Rodger NW, Dupré J. Continuous subcutaneous insulin infusion in the management of diabetes mellitus. Diabetes 1980; 29: 206–212. 10.2337/diab.29.3.206 PubMedWeb of Science®Google Scholar 12 Steno Study Group. Effect of 6 months of strict metabolic control on eye and kidney function in insulin-dependent diabetics with background retinopathy. Lancet: 1982; 1: 121–124. 10.1016/S0140-6736(82)90377-4 PubMedGoogle Scholar 13 Lauritzen T, Frost-Larsen K, Larsen H-W, et al. Effect of 1 year of near-normal blood glucose levels on retinopathy in insulin-dependent diabetics. Lancet 1983; 1: 200–204. 10.1016/S0140-6736(83)92585-0 CASPubMedWeb of Science®Google Scholar 14 Mecklenburg RS, Bensen JW, Beeker NM et al. Clinical use of the insulin infusion pump in 100 patients with type 1 diabetes. N Engl J Med 1982; 307: 513–518. 10.1056/NEJM198208263070901 CASPubMedWeb of Science®Google Scholar 15 Tamborlane WV, Sherwin RS, Kovisto V, Hendler R, Genel M, Felig P. Normalisation of the growth hormone and catecholamine response to exercise in juvenile-onset diabetic subjects treated with a portable insulin infusion pump. Diabetes 1979; 28: 785–788. 10.2337/diab.28.8.785 CASPubMedWeb of Science®Google Scholar 16 Viberti GC, Pickup JC, Bilous RW, Keen H, Mackintosh D. Correction of exercise-induced microalbuminuria in insulin-dependent diabetics after 3 weeks of subcutaneous insulin infusion. Diabetes 1981; 30: 818–823. 10.2337/diabetes.30.10.818 PubMedWeb of Science®Google Scholar 17 Koivisto V, Tronier B. Postprandial blood glucose response to exercise in type 1 diabetes: comparison between pump and injection therapy. Diabetes Care 1983; 6: 436–440. 10.2337/diacare.6.5.436 CASPubMedWeb of Science®Google Scholar 18 Dunn FL, Pietri A, Raskin P. Plasma lipid and lipoprotein levels with continuous subcutaneous insulin infusion in type 1 diabetes mellitus. Ann Int Med 1981; 95: 426–431. 10.7326/0003-4819-95-4-426 CASPubMedWeb of Science®Google Scholar 19 Raskin P, Pietri A, Unger RH. Changes in glucagon levels after four to five weeks of glucoregulation by portable insulin infusion pumps. Diabetes 1979; 28: 1033–1035. 10.2337/diabetes.28.11.1033 PubMedWeb of Science®Google Scholar 20 Rizza RA, Gerich JE, Haymond MW et al. Control of blood sugar in insulin-dependent diabetes: comparison of an artificial endocrine pancreas, continuous subcutaneous insulin infusion, and intensified conventional insulin therapy. N Engl J Med 1980; 303: 1313–1318. 10.1056/NEJM198012043032301 CASPubMedWeb of Science®Google Scholar 21 Nelson JD, Marliss EB, Albisser AM, Zinman B. Role of continuous component in subcutaneous 'open loop' insulin delivery. Lancet 1980; 1: 1383–1386. 10.1016/S0140-6736(80)92654-9 CASPubMedWeb of Science®Google Scholar 22 Schiffrin A, Belmonte M. Multiple daily self-glucose monitoring: its essential role in long-term glucose control in insulin-dependent diabetic patients treated with pump and multiple subcutaneous injections. Diabetes Care 1982; 5: 479–484. 10.2337/diacare.5.5.479 CASPubMedWeb of Science®Google Scholar 23 Nathan DN. The importance of intensive supervision in determining the efficacy of insulin pump therapy. Diabetes Care 1983; 6: 295–297. 10.2337/diacare.6.3.295 CASPubMedWeb of Science®Google Scholar 24 Lauritzen T, Frost-Larsen K, Larsen H-W, Deckert T, Keiding N, Nielsen G. Continuous subcutaneous insulin infusion. Lancet 1983; 1: 1445–1446. 10.1016/S0140-6736(83)92394-2 CASPubMedWeb of Science®Google Scholar 25 Lauritzen T, Pramming S, Deckert T, Binder C. Pharmacokinetics of continuous subcutaneous insulin infusion. Diabetologia 1983; 24: 326–329. 10.1007/BF00251817 PubMedWeb of Science®Google Scholar 26 Calabresse G, Bueti A, Santeusanio F et al. Continuous subcutaneous insulin infusion treatment in insulin-dependent diabetic patients: a comparison with conventional optimised treatment in a long-term study. Diabetes Care 1982; 5: 457–465. 10.2337/diacare.5.5.457 PubMedWeb of Science®Google Scholar 27 Home PD, Capaldo B, Burrin JM, Worth R, Alberti KGMM. A crossover comparison of continuous subcutaneous insulin infusion (CSII) against multiple insulin injections in insulin-dependent diabetic subjects: improved control with CSII. Diabetes Care 1982; 5: 466–471. 10.2337/diacare.5.5.466 CASPubMedWeb of Science®Google Scholar 28 Nathan, DM, Lou P, Avruch J. Intensive conventional and insulin pump therapies in adult type 1 diabetes: A crossover study. Ann Int Med 1982; 97: 31–36. 10.7326/0003-4819-97-1-31 CASPubMedWeb of Science®Google Scholar 29 Schiffrin A, Belmonte M. Comparison between continuous subcutaneous insulin infusion and multiple injections of insulin. Diabetes 1982; 31: 255–264. PubMedWeb of Science®Google Scholar 30 Reeves ML, Seigler DE, Ryan EA, Skyler JS. Glycaemic control in insulin-dependent diabetes mellitus: comparison of outpatient intensified conventional therapy with continuous subcutaneous insulin infusion. Am J Med 1982; 72: 673–680. 10.1016/0002-9343(82)90479-X CASPubMedWeb of Science®Google Scholar 31 Sonnenberg G, Drescher N, Berger M, Zimmerman H. Subcutaneous insulin absorption by portable pump systems: comparison of bolus and square-wave application. In: International Symposium on Artificial Systems for Insulin Delivery, Assisi, 1981, Raven Press, in press. Google Scholar 32 Home PD, Pickup JC, Keen H, Alberti KGMM, Parsons JA, Binder C. Continuous subcutaneous insulin infusion: comparison of plasma insulin profiles after infusion or bolus injection of the mealtime dose. Metabolism 1981; 30: 439–442. 10.1016/0026-0495(81)90177-3 CASPubMedWeb of Science®Google Scholar 33 Lawson PM, Champion MC, Canny C et al. Continuous subcutaneous insulin infusion (CSII) does not prevent progression of proliferative and preproliferative retinopathy. Br J Ophthalmol 1982; 66: 762–766. 10.1136/bjo.66.12.762 CASPubMedWeb of Science®Google Scholar 34 Hooymans JMM, Ballegooie, EV, Schweitzer NMJ, Doorenbos H, Reitsma WD, Sluiter WJ. Worsening of diabetic retinopathy with strict control of blood sugar. Lancet 1982; 2: 438. 10.1016/S0140-6736(82)90464-0 CASPubMedWeb of Science®Google Scholar 35 White MC, Kohner EM, Pickup JC, Keen H. Reversal of diabetic retinopathy by continuous subcutaneous insulin infusion: a case report. Br J Ophthalmol 1981; 65: 307–311. 10.1136/bjo.65.5.307 CASPubMedWeb of Science®Google Scholar 36 Segato T, Midena E, Piermarocchi S, Crepaldi G, Tiengo A. The effect of continuous subcutaneous insulin infusion treatment on proliferative diabetic retinopathy. Am J Ophthalmol 1982; 94: 685–686. 10.1016/0002-9394(82)90023-X CASPubMedWeb of Science®Google Scholar 37 White NH, Waltman SR, Krupin T, Santiago JV. Reversal of abnormalities in ocular fluorophotometry in insulin-dependent diabetes after five to nine months of improved metabolic control. Diabetes 1982; 31: 80–85. PubMedWeb of Science®Google Scholar 38 Simonsen SE. The value of the oscillatory potential in selecting juvenile diabetics at risk of developing proliferative retinopathy. Act Ophthalmol 1980; 58: 865–878. 10.1111/j.1755-3768.1980.tb08312.x CASPubMedWeb of Science®Google Scholar 39 Kroc Study Group. Near-normal control of glycaemia does not retard progression of mild diabetic retinopathy. Diabetologia 1983; 25: 146. Google Scholar 40 Dahl-Jorgensen K, Hansen KF, Smeland E et al. Long-term strict control in type 1 (insulin-dependent) diabetes mellitus: effect on late diabetic complications. Diabetologia 1983; 25: 149. Google Scholar 41 Viberti GC, Bilous RW, Mackintosh D, Bending JJ, Keen H. Long-term correction of hyperglycaemia and progression of renal failure in insulin-dependent diabetes. Br Med J 1983; 286: 598–602. 10.1136/bmj.286.6365.598 CASPubMedWeb of Science®Google Scholar 42 Viberti GC, Pickup JC, Jarrett RJ, Keen H. Effect of control of blood glucose on urinary excretion of albumin and b̃2 microglobulin in insulin-dependent diabetes. N Engl J Med 1979; 300: 638–641. 10.1056/NEJM197903223001202 CASPubMedWeb of Science®Google Scholar 43 Viberti GC, Hill RD, Jarrett RJ, Argyropoulos A, Mahmud H, Keen H. Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus. Lancet 1982; 1: 1430–1432. 10.1016/S0140-6736(82)92450-3 CASPubMedWeb of Science®Google Scholar 44 Pietri A, Ehle AL, Raskin P. Changes in nerve conduction velocity after six weeks of glucoregulation with portable insulin infusion pumps. Diabetes 1980; 688–671. Google Scholar 45 Boulton AJM, Drury J, Clarke B, Ward JD. Continuous subcutaneous insulin infusion in the management of painful diabetic neuropathy. Diabetes Care 1982; 5: 386–390. 10.2337/diacare.5.4.386 CASPubMedWeb of Science®Google Scholar 46 Cicmir I, Kashiwagi S, Berger H, Koschinsky T, Gries FA. Improvement of autonomic nerve functions after one year of continuous subcutaneous insulin infusion. Diabetologia 1982; 25: 147. Web of Science®Google Scholar 47 Gambardella S, Napoli A, Spallone V et al. Improvement of peripheral and autonomic neuropathy during one year of treatment with continuous subcutaneous insulin infusion in type 1 (insulin-dependent) diabetes. Diabetologia 1983; 25: 155–156. Web of Science®Google Scholar 48 Sachse G, Neuzner J, Ferderlin K. Long-term effect on continuous subcutaneous insulin infusion therapy on the autonomic diabetic neuropathy of the cardiovascular system. Diabetologia 1983; 25: 191. Web of Science®Google Scholar 49 Pickup JC, Keen H, Viberti GC, Bilous RW. Patient reactions to long-term outpatient treatment with continuous subcutaneous insulin infusion. Br Med J 1981; 282: 766–768. 10.1136/bmj.282.6266.766 CASPubMedWeb of Science®Google Scholar 50 Rothwell D, Sutherland IA, Pickup JC, Bending JJ, Keen H, Parsons JA. A new miniature, open-loop, extracorporeal insulin infusion pump. J Biomed Eng 1983; 5: 178–184. 10.1016/0141-5425(83)90095-X CASPubMedWeb of Science®Google Scholar 51 Bending JJ, Pickup JC, Keen H, Rothwell D, Sutherland IA. Meeting the problems of first-generation insulin infusion pumps: clinical trial of a new miniature infuser. Diabetes Care 1983; 6: 452–458. 10.2337/diacare.6.5.452 CASPubMedWeb of Science®Google Scholar Citing Literature Volume1, Issue1May 1984Pages 27-32 ReferencesRelatedInformation
Referência(s)